Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the performance of the Cardioblate Closure Device to occlude the LAA
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Medtronic Cardiovascular
NCT07257614 · Dialysis, Chronic Kidney Disease (Stages 3b-5), and more
NCT05136417 · Left Atrial Appendage Occlusion
NCT06584370 · Atrial Fibrillation, Left Atrial Appendage Ligation, and more
NCT05671276 · Atrial Fibrillation, Left Atrial Appendage Occlusion, and more
NCT04524780 · Left Atrial Appendage Occlusion
Eisenhower Medical Center
Rancho Mirage, California
Yale University School of Medicine
New Haven, Connecticut
Northwestern Memorial Hospital
Chicago, Illinois
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions